Purchases and Sales Made in Q3 2023 in Celldex Therapeutics, Inc. (CLDX)
This table provides information about the institutional ownership of Celldex Therapeutics, Inc. (CLDX) during Q3 2023. The information is specifically focused on institutions that hold shares of Celldex Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2023
Q3 2023
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-10.5K- 2.2% |
$268K - $394K
|
468K
$9.88M
|
|
|
Nov 13, 2023
Q3 2023
|
Algert Global LLC
San Francisco, CA |
SELL
|
- |
-10.7K- 26.98% |
$271K - $399K
|
28.8K
$608K
|
|
|
Nov 13, 2023
Q3 2023
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-12.3K- 22.68% |
$312K - $460K
|
41.8K
$883K
|
|
|
Nov 09, 2023
Q3 2023
|
Group One Trading, L.P.
Chicago, IL |
SELL
|
- |
-13.6K- 43.39% |
$346K - $510K
|
17.8K
$375K
|
|
|
Nov 13, 2023
Q3 2023
|
Northern Trust Corp
Chicago, IL |
SELL
|
- |
-13.8K- 2.84% |
$352K - $518K
|
474K
$10M
|
|
|
May 14, 2024
Q3 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-25.9K- 5.92% |
$660K - $971K
|
412K
$8.69M
|
|
|
Nov 07, 2023
Q3 2023
|
Barclays PLC
London, X0 |
SELL
|
- |
-28.7K- 16.66% |
$730K - $1.07M
|
143K
$3.03M
|
|
|
Nov 14, 2023
Q3 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-31.1K- 7.01% |
$791K - $1.16M
|
412K
$8.69M
|
|
|
Nov 14, 2023
Q3 2023
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-37.1K- 37.21% |
$945K - $1.39M
|
62.7K
$1.32M
|
|
|
Nov 13, 2023
Q3 2023
|
Rafferty Asset Management, LLC
New York, NY |
SELL
|
- |
-40.7K- 19.81% |
$1.04M - $1.53M
|
165K
$3.48M
|
|
|
Nov 13, 2023
Q3 2023
|
Qube Research & Technologies LTD
London, X0 |
SELL
|
- |
-64.5K- 93.76% |
$1.64M - $2.42M
|
4.3K
$90.7K
|
|
|
Nov 14, 2023
Q3 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-84.8K- 93.47% |
$2.16M - $3.18M
|
5.93K
$125K
|
|
|
Nov 09, 2023
Q3 2023
|
Dimensional Fund Advisors LP
Austin, TX |
SELL
|
- |
-112K- 24.75% |
$2.86M - $4.21M
|
341K
$7.2M
|
|
|
Nov 14, 2023
Q3 2023
|
Eversept Partners, LP
New York, NY |
SELL
|
- |
-198K- 25.15% |
$5.03M - $7.4M
|
588K
$12.4M
|
|
|
Nov 13, 2023
Q3 2023
|
Candriam S.C.A.
|
SELL
|
- |
-228K- 41.42% |
$5.8M - $8.54M
|
323K
$6.8M
|
|
|
Nov 14, 2023
Q3 2023
|
State Street Corp
Boston, MA |
SELL
|
- |
-434K- 15.93% |
$11.1M - $16.3M
|
2.29M
$48.4M
|
|
|
Oct 31, 2023
Q3 2023
|
Jennison Associates LLC
|
SELL
|
- |
-1.3M- 97.98% |
$33.1M - $48.8M
|
26.9K
$567K
|